Bouw Studie Maes SRL

Bouw Studie Maes reported total assets of 438,224 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).

Company number (CBE) 0436.196.429 · VAT BE0436196429
8930 Menen
active in Office administrative and support activities (NACE 82100)
operating since 22 Dec 1988 (≈ 38 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Bouw Studie Maes shows with a free account.

See the score
Profile
SRL since 1988
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−1,755 €
Equity434,706 €
Cash16,963 €
Total assets438,224 €
The line marks its sector median: 53.2% (1554 companies).

Change 2022 → 2025: Equity -3 % Total assets -11 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Bouw Studie Maes's annual accounts

20252024202320222021
Net result−1,755 €
Equity434,706 €
Cash16,963 €
Total assets438,224 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Jul 2026
  • Year ended 31 Dec 2024filed on 15 May 2025
  • Year ended 31 Dec 2023filed on 03 Apr 2024
  • Year ended 31 Dec 2022filed on 20 Feb 2023
  • Year ended 31 Dec 2021filed on 16 Feb 2022

Bouw Studie Maes's financial analysis

Management and control of Bouw Studie Maes

1 active director(s) in the register.

Bouw Studie Maes's shareholders and holdings →

Bouw Studie Maes's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0436.196.429
VAT number
BE0436196429
Peppol
Registered · 0208:0436196429 · as of 10 Nov 2026
Legal form
SRL
Incorporated
22 Dec 1988
Registered office
8930 Menen
Latest accounts
2025 · filed on 31 Jul 2026
Activity
Office administrative and support activities (NACE 82100)

Bouw Studie Maes (SRL) has been based in Menen since 1988, active in: office administrative and support activities. For 2025, it reports a net loss of 1,755 € and equity of 434,706 €; its revenue is not published. Its solvency stands at 99.2%, above the median of its sector (53.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Bouw Studie Maes

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Bouw Studie Maes

What is the revenue of Bouw Studie Maes?

Bouw Studie Maes files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Bouw Studie Maes?

In Belgium, the VAT number is the company number prefixed with BE: BE0436196429 for Bouw Studie Maes, if the company is VAT-registered. Its company number (CBE) is 0436.196.429.

Where is the registered office of Bouw Studie Maes?

According to the CBE register, the registered office of Bouw Studie Maes is in 8930 Menen.

What is the equity of Bouw Studie Maes?

At the close of the 2025 financial year, the equity of Bouw Studie Maes amounts to 434,706 €, a solvency of 99.2% of total assets.

Who manages Bouw Studie Maes?

The register lists 1 active mandates at Bouw Studie Maes. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Bouw Studie Maes

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 03 Aug 2026

No credit card, no commitment.

What each plan unlocks →